West Pharma earnings show it's more than a GLP-1 play. Why we see more upside

5 hours ago

Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx

8 hours ago

Merck tops estimates, hikes profit outlook on strength of injectable Keytruda

8 hours ago

Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand

14 hours ago

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers

14 hours ago

Measles resurgence exposes deeper weaknesses in U.S. public health, experts say

2 days ago

Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock

2 days ago

Amgen says drug combo slashes risk of death by 58% in patients with lung cancer

3 days ago

Doctors call Moderna, Merck's cancer vaccine data a major advancement

5 days ago

Moderna shares plunge after cancer vaccine data leaks — despite positive results

7 days ago

New bipartisan bill aims to speed up clinical trials for rare disease treatments

7 days ago

Novo's CagriSema obesity drug shows 25% weight loss in women in analysis

7 days ago

Sickle cell gene therapies offer new hope, but access remains a major challenge

13 days ago

Here's our monthly update on our 32 stocks, including 2 more names to buy

14 days ago

Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time

14 days ago

What Maven CEO Kate Ryder tells her kids every day amid AI education threat

15 days ago

Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost

15 days ago

UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs

16 days ago

Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock

17 days ago

Jim Cramer week ahead: Bank earnings, ASML and TSMC

17 days ago

For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come

20 days ago

Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday

22 days ago

Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia

22 days ago

Jim Cramer says Grail can run higher as FDA decision on Galleri nears

22 days ago

Russian lab worker's suspected plague death leaves experts puzzled

23 days ago

Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk

23 days ago

AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos

23 days ago

Russian lab worker dies amid plague reports. Here's what we know

24 days ago

Russia hospitalizes almost 200 people after death from plague: Reports

24 days ago

BioMarin reports five-year Pompe disease data showing durable motor function

27 days ago

Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s

27 days ago

Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion

27 days ago